Biogen Idec’s Business Development group aims to be flexible and creative, responding to potential partners quickly and thoughtfully. Our BD teams in San Diego, Cambridge and Europe work together to ensure that opportunities receive proper attention.
Partnering opportunities are first screened for strategic fit with our therapeutic areas of interest. Further evaluation is done by our Alliance Review Committees: therapeutically focused panels that evaluate opportunities from a clinical, scientific, legal and commercial perspective. This cross-functional evaluation provides for senior management endorsement early in the process, helping to expedite subsequent partnering discussions.
Our deal teams include people who will continue to work on the program after the deal is signed, enhancing the integration of the program and building strong relationships.